Literature DB >> 11441827

Levofloxacin-resistant Streptococcus pneumoniae: second look.

C Thornsberry, J A Karlowsky, D F Sahm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11441827      PMCID： PMC90629          DOI： 10.1128/AAC.45.7.2183-2184.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  21 in total

1.  Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae.

Authors:  G W Wortmann; S P Bennett
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

2.  Fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  D E Peterson; D F Sahm
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

3.  Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong.

Authors:  P L Ho; T L Que; D N Tsang; T K Ng; K H Chow; W H Seto
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States.

Authors:  M E Jones; A M Staples; I Critchley; C Thornsberry; P Heinze; H D Engler; D F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Pneumococcal resistance in the UK.

Authors:  C E Goldsmith; J E Moore; P G Murphy
Journal:  J Antimicrob Chemother       Date:  1997-12       Impact factor: 5.790

6.  In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis.

Authors:  C Janoir; I Podglajen; M D Kitzis; C Poyart; L Gutmann
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

7.  Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

Authors:  D K Chen; A McGeer; J C de Azavedo; D E Low
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

8.  Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci.

Authors:  I González; M Georgiou; F Alcaide; D Balas; J Liñares; A G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

9.  Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study.

Authors:  C Thornsberry; P T Ogilvie; H P Holley; D F Sahm
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

10.  The three major Spanish clones of penicillin-resistant Streptococcus pneumoniae are the most common clones recovered in recent cases of meningitis in Spain.

Authors:  M C Enright; A Fenoll; D Griffiths; B G Spratt
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948
View more
  1 in total

1.  Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.

Authors:  George P Allen; Glenn W Kaatz; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.